RLAY News
Archived Headlines
- US IPO Week Ahead: GoHealth takes the lead in a 9 IPO Week 07/10/20
- Solid tumor biotech Relay Therapeutics sets terms for $250 million IPO 07/09/20
- US IPO Weekly Recap: Agora pops 153% while Albertsons falls flat in a 6 IPO week 06/26/20
- Phase 1 oncology biotech Relay Therapeutics files for a $200 million IPO 06/24/20
US IPO Week Ahead: The IPO market takes a breather in a 4 IPO week
Updated Monday, 8/10 After an active July, the US IPO market is taking a breather. Three companies are scheduled to raise $2.5 billion in the week ahead, led by Chinese real estate giant KE Holdings (BEKE). KE Holdings...read more
US IPO Weekly Recap: nCino pops 195% in 8 IPO week
Eight IPOs and six SPACs entered public markets this past week, led by nCino (NCNO), which ...read more
Solid tumor biotech Relay Therapeutics prices upsized IPO at $20, above the upwardly revised range
Relay Therapeutics, a Phase 1 biotech developing precision small molecule therapies for solid tumors, raised $400 million by offering 20 million shares at $20, above the upwardly revised range of $18 to $19. The company originally planned to offer 14.7 million...read more
Solid tumor biotech Relay Therapeutics increases proposed deal size by 48% ahead of $370 million IPO
Relay Therapeutics, a Phase 1 biotech developing precision small molecule therapies for solid tumors, raised the proposed deal size for its upcoming IPO on Wednesday. The Cambridge, MA-based company now plans to raise $370 million by offering 20 million...read more